DPP3 and Shock: To this end, DPP3 plasma concentrations were measured in samples from a subcohort of healthy subjects participating in the Malmö Preventive project, as well as in admission samples from critically ill patients with severe sepsis (175 patients) and septic shock (153 patients) who were randomly selected from the AdrenOSS-1 trial.